Smithy You on the right board?
Bit of confusion on the time posting 1 hour to go. The Corporate Update Call Presentation is @21.15 GMT tonight 2/12/20 ( 16:15 ET time )
Interesting to hear the updates.
Australia Stock Exchange is open until:
Wed, Dec 2, 16:00 +11:00
We will get news tomorrow ( Oz time difference ?) hopefully we will have had the funding all sorted and moving on up. The funding might be 10% which will not have an impact but anything a lot larger then a reassessment on the SP against MCAP.
Once we get the news I see us going north all the way until Q1 2021 then the SP @24 will look like a bargain.
I see this as a temporary funding to cover the stop gap. We end up with more cash on the balance sheet at the end.
I will be in once I see it steady and bottom around 24p is good support at the moment with some buying support .
I was still looking at topping up and see this as an opportunity. The fundamentals have not changed for me and I see upside once the dust settles. End of Q1 is still a big mile stone in my calendar for this company. Black Friady bargain might be here for the pickings.
What do we think the upshot of the RNS suspension on the SP today.
The lock down is obviously affecting peoples discussions. The fundamentals of this company have not changed. We have excellent tech and soon to be launched which will take the market by storm. It's easy if you are impatient and sell out missing the launch it's up to you. FOMO stay invested.
trilla1337 Yes I know AVCT aren't in the RCT right. That's why I said "we" as in ODX in the RTC which is this board . May be you took it as I posted it in the Avacta heading HAHA
We are in on the RTC so if news drops tomorrow this looks a bargain.
DB explain India ICRM supply of testing incomparable using automated extraction. Package inserts had to be changed then resubmitted and no communication for over two months really disappointing.
Now in November full engaged and expect approval in very very near future for all three kits and Genedrive exporter software. Taken from the presentation.
Will sell in US without Beckman which means we are not tied. Great news. Sell without FDA approval another chestnut.
Very slick presentation with lots of facts and the pipeline slide 0-6 months short term looks like all good news.
I have come away with a very positive outlook.
I will be listening very closely for some positive news. I am an ever optimist with this share. Been in GDR a long time since the fund raise and believe they have a good product. They need a new sales force and approval process which needs to turn into sales in Q1 2021. When we hit the low I will be topping up. Tomorrow will be interesting to see where the SP goes.
Nice RNS and dividend pay out confirmed also confirmed tower sell off in Q1 2021 which will be a nice cash sale.
All good news and good rises in EBITA . This is a good indicator and revenue generator.
With 5G rollout across a number of countdown and cities we should be in a good position.
The plan to grow the customer base is coming together and consider Vodafone management team have turned this round.